Services of MTRC

The focus of the service is on reimbursement decisions (new procedure codes, DRG change, coverage decisions, innovation funding, clinical guidelines) in 14 European countries and globally. Only in Europe, 29 organizations are monitored. All news are classified by 31 Technology Group and alerts are sent every 2 weeks. This is a twin service for "HTA Alerts", where we track initiated or published HTAs from 56 organizations globally.

For the last three years, MTRC maintained a be-weekly newsletter with information about reimbursement and market access changes in European countries. From July 2020, we are extending this activity with an introduction of the paid subscription service HTA Alerts. It will include bi-weekly reports about initiated or published HTAs from 56 HTA organizations worldwide. Reports will be customized so that the clients receive notification for only relevant technologies.

The report summarizes information about HTA activity in 12 European countries (+EUnetHTA), including 51 HTA organizations. Data for all non-pharmaceutical published HTAs in 2019 are reported. In total, 256 reports are reported (in 2018, 337 reports were released by the same organizations). The largest number of reports were published in England (108 reports, 42%), Sweden (34 reports, 13%) and Spain (26 reports, 10%). All reports are classified using 31 technological groups. The most common types of technologies covered by HTA reports were in-vitro diagnostic (38 reports, 15%) and cardiovascular (25 reports, 10%) ones.

MTRC released a novel product, which was often requested by our clients from marketing, market intelligence, clinical affairs and other non-market access departments. The online seminar includes a basic overview of the market access, clinical evidence, value claims management and health economics for the Med Tech non-market access professionals. Available in the form of presentation (89 slides) and a pre-recorded webinar (2.5 hours).

MTRC released the report on reimbursement of diagnostic testing for COVID-19 in six European countries (Belgium, France, Germany, Netherlands, Switzerland and Turkey). The report includes information about the availability of reimbursement, types of tests reimbursed, testing criteria. Download sample pages to assess the relevance of the report.